Latest Earnings Call / Transcript of CytoDyn (CYDY) We haven't found the most latest Earnings Call recordings yet. Stay tuned and we'll add it here as soon as we found it.
Earnings History Date EPS / Forecast Revenue / Forecast February 1, 2023 - / -0.04- / -January 9, 2023 -0.03 / -0.04- / -November 2, 2022 -0.03 / -0.05- / -August 3, 2022 -0.15 / -0.04- / -April 27, 2022 -0.05 / -0.04- / -February 2, 2022 -0.05 / -0.04225.0K / -Beat! November 3, 2021 -0.05 / -0.0541.00K / -Beat! July 28, 2021 -0.08 / -0.0541.00K / -Beat! April 28, 2021 -0.05 / -0.05- / -February 3, 2021 -0.06 / -0.05- / -October 28, 2020 -0.06 / -0.06- / -July 29, 2020 -0.12 / -0.05- / 200KApril 29, 2020 -0.08 / -0.08- / 1MJanuary 29, 2020 -0.04 / -0.04- / 100KOctober 30, 2019 -0.04 / -0.0450K / 50KJuly 31, 2019 -0.05 / -0.041.2M / -Beat! May 1, 2019 -0.04 / -0.04- / -January 30, 2019 -0.06 / -0.05- / -October 31, 2018 -0.07 / -0.06- / -August 1, 2018 -0.05 / -0.07- / -May 2, 2018 -0.1 / -0.07- / -
News about CytoDyn earnings
CytoDyn hit by clinical holds on HIV and COVID-19 programs in the U.S. seekingalpha.com Mar 31, 2022 5:09 am
Morgan Stanley projects about a third of biotechs will need financing in 2022 seekingalpha.com Mar 27, 2022
Long COVID, the next frontier for vaccine and drug developers seekingalpha.com Mar 26, 2022 1:36 am
Short-term bounce for CytoDyn following CEO ousting not enough to stop slide seekingalpha.com Jan 31, 2022 11:38 pm
Ousting of CytoDyn CEO Pourhassan boosts stock; shares up 12% seekingalpha.com Jan 27, 2022 1:30 am
CytoDyn announces change in leadership to support approval and commercialization of leronlimab seekingalpha.com Jan 26, 2022 7:15 am
CytoDyn's leronlimab in 350 mg weekly dose met endpoints in Phase 2 NASH trial seekingalpha.com Jan 5, 2022 10:38 pm
CytoDyn receives positive response from FDA for Phase 3 leronlimab study in COVID-19 seekingalpha.com Dec 21, 2021 10:28 pm
CytoDyn files for expanded access use of leronlimab for HIV patients seekingalpha.com Dec 9, 2021 10:13 pm
CytoDyn reports leronlimab data in NASH trial for first 15 patients seekingalpha.com Nov 24, 2021 11:08 pm
CytoDyn submits the first section of HIV BLA to FDA under rolling review seekingalpha.com Nov 16, 2021 8:07 pm
CytoDyn submits leronlimab Breakthrough Therapy designation application to the FDA seekingalpha.com Nov 8, 2021 8:50 pm
CytoDyn posts preliminary results from mid-stage leronlimab NASH study seekingalpha.com Nov 3, 2021 6:11 pm
CytoDyn treats first patient in late-stage leronlimab Brazil COVID-19 trial seekingalpha.com Oct 25, 2021 6:26 pm
CytoDyn says Court ruled activist groupâs nominations were Invalid seekingalpha.com Oct 14, 2021 7:52 pm
CytoDyn announces legal actions against its former CRO, Amarex Clinical Research seekingalpha.com Oct 7, 2021 7:10 pm
CytoDyn launches leronlimab study with immune checkpoint blockade for breast cancer seekingalpha.com Oct 7, 2021 6:55 pm
CytoDyn activists send Ziff/Bain Capital presentation critical of CEO to shareholders seekingalpha.com Oct 4, 2021 10:35 pm
Cytodyn management calls activist group leronlimab plan 'misguided' and 'misleading' seekingalpha.com Sep 29, 2021 9:07 pm
CytoDyn shareholder group unveils plan to obtain cancer therapy approval for Leronlimab seekingalpha.com Sep 24, 2021 8:52 pm
CytoDyn files application to uplist to Nasdaq; shares +4% seekingalpha.com Jul 16, 2020 11:20 pm
FDA rejects CytoDyn's leronlimab application for HIV seekingalpha.com Jul 13, 2020 6:34 pm
CytoDyn inks distribution deal for leronlimab for COVID-19 seekingalpha.com Jul 6, 2020 3:52 pm
Citron pulls bearish Cytodyn report seekingalpha.com Jul 1, 2020 9:42 pm
CytoDyn down 32% on bearish Citron report seekingalpha.com Jul 1, 2020 3:22 am
CytoDyn and NIH of Mexico to conduct COVID-19 Phase 3 trial seekingalpha.com Jun 29, 2020 6:37 pm
Bad COVID news is good news for COVID vaccine & drugmakers seekingalpha.com Jun 25, 2020 2:12 am
CytoDyn to update on pipeline progress on June 11 seekingalpha.com Jun 9, 2020 7:30 pm
CytoDyn gives Mulholland permanent CFO job seekingalpha.com Jun 3, 2020 6:19 am
CytoDyn requests for priority review of Leronlimab BLA for HIV seekingalpha.com Jun 1, 2020 6:13 pm
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.